Skip to main content
. Author manuscript; available in PMC: 2018 May 30.
Published in final edited form as: Eur J Pharm Sci. 2017 Mar 3;103:85–93. doi: 10.1016/j.ejps.2017.03.003

Table 2.

Cisplatin release in the presence of serum and cytotoxicity against the C26 cells in culture.

Name Formulation % Release after 72 h IC50 (uM)
C8Chems Chems:PEG (95:5) 26% 5.0
DChems/DPPC DChems:DPPC:PEG (32:63:5) 20% 5.8
C16Chems Chems:PEG (95:5) <5% 79
C18:1Chems Chems:PEG (95:5) <5% >115
DChems DChems:PEG (95:5) <5% 53
HSPC HSPC:Chol:PEG (51:44:5) <5% 260
POPC 51 POPC:Chol:PEG (51:44:5) 14% 130
POPC 80 POPC:Chol:PEG (80:15:5) 37% 5.9